Literature DB >> 35152429

Diffusion tensor imaging correlates of depressive symptoms in Parkinson disease.

Lauren Uhr1, Evangelia Tsolaki1, Nader Pouratian2.   

Abstract

Depression is a heterogeneous clinical syndrome prevalent in patients with Parkinson disease (PD) that remains incompletely understood. Further, the differences in biomarkers of depression in PD and in non-PD patients are unclear. The subcallosal cingulate cortex (SCC) and its connections have been implicated in the pathophysiology of major depressive disorder (MDD). Diffusion tensor imaging (DTI) provides a tool to quantify MDD-related structural abnormalities underlying depressive symptoms in PD. Diffusion-weighted magnetic resonance imaging data were collected from 31 patients with PD. Depression symptom severity was measured using the Beck Depression Inventory (BDI-II), and assessed using three subscales: dysphoric mood, loss of interest/pleasure, and somatic symptoms. Probabilistic tractography methods were used to quantify the SCC connectivity to target regions in cortico-limbic-striatal network (ventral striatum, medial prefrontal cortex [mPFC], dorsal anterior cingulate cortex, and uncinate fasciculus), while fractional anisotropy (FA) was calculated in predefined white matter regions of interest. DTI data were correlated with severity of depression across three domains. SCC-mPFC connectivity in the left hemisphere was positively correlated with severity of dysphoric mood (Benjamini-Hochberg adjusted p = .02). Region of interest-based analyses demonstrated a significant and distinct topographic association between FA and dysphoric mood, loss of interest/pleasure, and somatic symptom severity, although these findings did not maintain significance after applying the false discovery rate correction. Abnormal SCC connectivity underlies depressive symptoms in both PD and MDD, suggesting that interventions used for MDD should be explored in treating depressive symptoms in PD, particularly depression dominated by dysphoric mood.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  Parkinson disease; depression; diffusion; medial prefrontal cortex; subcallosal cingulate

Mesh:

Year:  2022        PMID: 35152429      PMCID: PMC9119905          DOI: 10.1002/cne.25310

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.028


  30 in total

1.  Characterization and propagation of uncertainty in diffusion-weighted MR imaging.

Authors:  T E J Behrens; M W Woolrich; M Jenkinson; H Johansen-Berg; R G Nunes; S Clare; P M Matthews; J M Brady; S M Smith
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

2.  Minor depression and brain perfusion images in Parkinson's disease.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Using probabilistic tractography to target the subcallosal cingulate cortex in patients with treatment resistant depression.

Authors:  Evangelia Tsolaki; Randall Espinoza; Nader Pouratian
Journal:  Psychiatry Res Neuroimaging       Date:  2017-01-20       Impact factor: 2.376

5.  DTI correlates of distinct cognitive impairments in Parkinson's disease.

Authors:  Zhong Zheng; Shirag Shemmassian; Christopher Wijekoon; Won Kim; Susan Y Bookheimer; Nader Pouratian
Journal:  Hum Brain Mapp       Date:  2013-02-18       Impact factor: 5.038

6.  Age- and disease-related cerebral white matter changes in patients with Parkinson's disease.

Authors:  Laura J de Schipper; Anne Hafkemeijer; Mark J R J Bouts; Jeroen van der Grond; Johan Marinus; Johanna M L Henselmans; Jacobus J van Hilten
Journal:  Neurobiol Aging       Date:  2019-05-13       Impact factor: 4.673

Review 7.  Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging.

Authors:  Jing Jiang; You-Jin Zhao; Xin-Yu Hu; Ming-Ying Du; Zi-Qi Chen; Min Wu; Kai-Ming Li; Hong-Yan Zhu; Poornima Kumar; Qi-Yong Gong
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

8.  Disrupted white matter integrity in depressed versus non-depressed Parkinson's disease patients: a tract-based spatial statistics study.

Authors:  Peiyu Huang; Xiaojun Xu; Quanquan Gu; Min Xuan; Xinfeng Yu; Wei Luo; Minming Zhang
Journal:  J Neurol Sci       Date:  2014-08-14       Impact factor: 3.181

9.  Resting-state fMRI study on drug-naive patients with Parkinson's disease and with depression.

Authors:  Chunyan Luo; Qin Chen; Wei Song; Ke Chen; Xiaoyan Guo; Jing Yang; Xiaoqi Huang; Qiyong Gong; Hui-Fang Shang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-13       Impact factor: 10.154

10.  White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group.

Authors:  Laura S van Velzen; Sinead Kelly; Dmitry Isaev; Andre Aleman; Lyubomir I Aftanas; Jochen Bauer; Bernhard T Baune; Ivan V Brak; Angela Carballedo; Colm G Connolly; Baptiste Couvy-Duchesne; Kathryn R Cullen; Konstantin V Danilenko; Udo Dannlowski; Verena Enneking; Elena Filimonova; Katharina Förster; Thomas Frodl; Ian H Gotlib; Nynke A Groenewold; Dominik Grotegerd; Mathew A Harris; Sean N Hatton; Emma L Hawkins; Ian B Hickie; Tiffany C Ho; Andreas Jansen; Tilo Kircher; Bonnie Klimes-Dougan; Peter Kochunov; Axel Krug; Jim Lagopoulos; Renick Lee; Tristram A Lett; Meng Li; Frank P MacMaster; Nicholas G Martin; Andrew M McIntosh; Quinn McLellan; Susanne Meinert; Igor Nenadić; Evgeny Osipov; Brenda W J H Penninx; Maria J Portella; Jonathan Repple; Annerine Roos; Matthew D Sacchet; Philipp G Sämann; Knut Schnell; Xueyi Shen; Kang Sim; Dan J Stein; Marie-Jose van Tol; Alexander S Tomyshev; Leonardo Tozzi; Ilya M Veer; Robert Vermeiren; Yolanda Vives-Gilabert; Henrik Walter; Martin Walter; Nic J A van der Wee; Steven J A van der Werff; Melinda Westlund Schreiner; Heather C Whalley; Margaret J Wright; Tony T Yang; Alyssa Zhu; Dick J Veltman; Paul M Thompson; Neda Jahanshad; Lianne Schmaal
Journal:  Mol Psychiatry       Date:  2019-08-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.